Bill Rote

Senior Vice President of Research and Development

Other

Earnings-call appearances

Travere Therapeutics FDA Approval of FILSPARI in FSGS Conference Call
Travere Therapeutics, Inc. (TVTX)

2026-04-13
Travere Therapeutics, Inc. Q4 FY2025 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2026-02-19
Travere Therapeutics, Inc. Q3 FY2024 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2024-10-31
Travere Therapeutics, Inc. Q3 FY2023 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2023-11-07
Travere Therapeutics, Inc. Q1 FY2022 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2022-05-05
Travere Therapeutics, Inc. Q4 FY2021 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2022-01-10
Travere Therapeutics, Inc. Q3 FY2021 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2021-10-28
Travere Therapeutics, Inc. Q2 FY2021 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2021-07-29
Travere Therapeutics, Inc. Q1 FY2021 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2021-05-06
Travere Therapeutics, Inc. Q4 FY2020 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2021-02-10
Travere Therapeutics, Inc. Q3 FY2020 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2020-11-05
Travere Therapeutics, Inc. Q1 FY2020 Earnings Call
Travere Therapeutics, Inc. (TVTX)

2020-05-11